An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2022 - Elsevier
Background and aims Molnupiravir is a newer oral antiviral drug that has recently received
emergency use authorization (EUA) in USA, UK and India. We aim to conduct an update on …

[HTML][HTML] An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic …, 2022 - ncbi.nlm.nih.gov
Methods We systematically searched the electronic database of PubMed, MedRxiv and
Google Scholar until January 5, 2022, using key MeSH keywords. Results Final result of …

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19.

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic …, 2022 - europepmc.org
Methods We systematically searched the electronic database of PubMed, MedRxiv and
Google Scholar until January 5, 2022, using key MeSH keywords. Results Final result of …

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

AK Singh, A Singh, R Singh… - Diabetes & metabolic …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and aims Molnupiravir is a newer oral antiviral drug that has recently received
emergency use authorization (EUA) in USA, UK and India. We aim to conduct an update on …

[引用][C] An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2022 - cir.nii.ac.jp
An updated practical guideline on use of molnupiravir and comparison with agents having
emergency use authorization for treatment of COVID-19 | CiNii Research CiNii 国立情報学 …